PTIE Pain Therapeutics Inc.

1.12
-0.03  -3%
Previous Close 1.15
Open 1.13
Price To Book 0.97
Market Cap 19285616
Shares 17,219,300
Volume 109,267
Short Ratio
Av. Daily Volume 287,972

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued September 26, 2016. NDA refiled but additional CRL issued August 6, 2018. Noted November 12, 2018 that it will meet with the FDA January 31, 2019 to discuss further.
Remoxy
Chronic pain
Phase 2 trial initiation announced December 6, 2018.
PTI-125
Alzheimer’s disease